Ahmed Al Hasan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ahmed Al Hasan has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Floor Reimann
Department of Rheumatology, Frisius Medical Centre, Leeuwarden, the Netherlands
2 shared publications - Freke Wink
Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2 shared publications - Reinhard Bos
Department of Rheumatology, Frisius MC, Leeuwarden, the Netherlands
2 shared publications A. Iqbal
1 shared publicationA. Zia
1 shared publication- Afsheen N. Iqbal
Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
1 shared publication
Latest Publications
- Open Access
- 17 November 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e77345
Evaluating the Accuracy of the Frysian Questionnaire for Differentiation of Musculoskeletal Complaints for Triage of Musculoskeletal Diseases: Algorithm Development and Validation Study
Background: Inflammatory rheumatic diseases (IRDs) affect 5% of the general population, whereas 35% of the population experiences musculoskeletal concerns. IRDs cause early disability, reduced life expectancy, and considerable health care costs. Early diagnosis is essential to prevent long-term damage. Similarly important is the early identification of patients with musculoskeletal concerns without IRDs to prevent unnecessary health care expenses. Of the population referred to the rheumatologist, 60% have noninflammatory musculoskeletal concerns, whereas only 20% of patients with an IRD see a rheumatologist within 3 months of symptom onset. The need for digital predictive (triage) tools for rheumatic and musculoskeletal diseases led to the development of the Frysian Questionnaire for Differentiation of Musculoskeletal Complaints (FRYQ). Objective: This study aimed to assess whether the FRYQ can distinguish IRD from noninflammatory musculoskeletal concerns in general, and rheumatoid arthritis and fibromyalgia specifically, in newly referred patients. Methods: The FRYQ is an 87-item tool (20 open-ended and 67 closed-ended questions) used to triage new rheumatology patients at Frisius Medical Center in the Netherlands. We analyzed data from 2 sources: dataset A with 728 outpatient clinic patients and dataset B with 373 patients from the Joint Pain Assessment Scoring Tool study. We built a classifier using Extreme Gradient Boosting to distinguish inflammatory from noninflammatory conditions based on closed-ended questions. Using elastic net regularization, we identified the most informative questions. We evaluated classification using receiver operating characteristic curve analysis and assessed feature importance through Shapley Additive Explanation analysis. To test generalizability, we replicated our analysis on dataset B. Finally, we examined whether the questions of the FRYQ could be used to identify specific conditions beyond the general categories of IRD and non-IRD, specifically for detecting fibromyalgia and rheumatoid arthritis. Results: Feature selection reduced the questionnaire from 67 to 28 items while maintaining discriminative power. After initial development, the model achieved an area under the receiver operating characteristic curve (AUC-ROC) of 0.72 (95% CI 0.67-0.78) for distinguishing inflammatory from noninflammatory conditions in an external validation set. Using a probability threshold of 0.30, the model achieved 71% sensitivity and 56% specificity on external validation. The FRYQ demonstrated stronger performance in identifying specific diagnoses such as fibromyalgia (AUC-ROC=0.81) and rheumatoid arthritis (AUC-ROC=0.77). Key discriminating features included symptom duration, pain response to movement, and anti-inflammatory medication effectiveness. Conclusions: The FRYQ effectively distinguishes inflammatory from noninflammatory rheumatic conditions before specialist consultation and shows particular strength in identifying fibromyalgia and rheumatoid arthritis. This tool could improve rheumatology triage by prioritizing referrals with high likelihood of IRD for early rheumatologist evaluation while directing other patients to appropriate alternative resources. Prospective studies are needed to determine the FRYQ’s impact on clinical outcomes and health care efficiency.
- 17 November 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e77345
Open AccessEvaluating the Accuracy of the Frysian Questionnaire for Differentiation of Musculoskeletal Complaints for Triage of Musculoskeletal Diseases: Algorithm Development and Validation Study
Background: Inflammatory rheumatic diseases (IRDs) affect 5% of the general population, whereas 35% of the population experiences musculoskeletal concerns. IRDs cause early disability, reduced life expectancy, and considerable health care costs. Early diagnosis is essential to prevent long-term damage. Similarly important is the early identification of patients with musculoskeletal concerns without IRDs to prevent unnecessary health care expenses. Of the population referred to the rheumatologist, 60% have noninflammatory musculoskeletal concerns, whereas only 20% of patients with an IRD see a rheumatologist within 3 months of symptom onset. The need for digital predictive (triage) tools for rheumatic and musculoskeletal diseases led to the development of the Frysian Questionnaire for Differentiation of Musculoskeletal Complaints (FRYQ). Objective: This study aimed to assess whether the FRYQ can distinguish IRD from noninflammatory musculoskeletal concerns in general, and rheumatoid arthritis and fibromyalgia specifically, in newly referred patients. Methods: The FRYQ is an 87-item tool (20 open-ended and 67 closed-ended questions) used to triage new rheumatology patients at Frisius Medical Center in the Netherlands. We analyzed data from 2 sources: dataset A with 728 outpatient clinic patients and dataset B with 373 patients from the Joint Pain Assessment Scoring Tool study. We built a classifier using Extreme Gradient Boosting to distinguish inflammatory from noninflammatory conditions based on closed-ended questions. Using elastic net regularization, we identified the most informative questions. We evaluated classification using receiver operating characteristic curve analysis and assessed feature importance through Shapley Additive Explanation analysis. To test generalizability, we replicated our analysis on dataset B. Finally, we examined whether the questions of the FRYQ could be used to identify specific conditions beyond the general categories of IRD and non-IRD, specifically for detecting fibromyalgia and rheumatoid arthritis. Results: Feature selection reduced the questionnaire from 67 to 28 items while maintaining discriminative power. After initial development, the model achieved an area under the receiver operating characteristic curve (AUC-ROC) of 0.72 (95% CI 0.67-0.78) for distinguishing inflammatory from noninflammatory conditions in an external validation set. Using a probability threshold of 0.30, the model achieved 71% sensitivity and 56% specificity on external validation. The FRYQ demonstrated stronger performance in identifying specific diagnoses such as fibromyalgia (AUC-ROC=0.81) and rheumatoid arthritis (AUC-ROC=0.77). Key discriminating features included symptom duration, pain response to movement, and anti-inflammatory medication effectiveness. Conclusions: The FRYQ effectively distinguishes inflammatory from noninflammatory rheumatic conditions before specialist consultation and shows particular strength in identifying fibromyalgia and rheumatoid arthritis. This tool could improve rheumatology triage by prioritizing referrals with high likelihood of IRD for early rheumatologist evaluation while directing other patients to appropriate alternative resources. Prospective studies are needed to determine the FRYQ’s impact on clinical outcomes and health care efficiency.
- 27 January 2022
- Published by Springer Nature in Rheumatology International
- Vol. 42 (11) , 2019-2026
Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry
The Handscan is a novel objective optical imaging device for disease follow-up and management in rheumatoid arthritis patients. We aim to examine the association between the baseline outcomes of the Handscan, disease activity levels and joint swelling. The Handscan measures differences in laser light absorption between joints of fingers and wrists and adjacent reference tissue, indicating the presence or absence of inflammation. The device gives an optical spectral transmission (OST) index per joint. The average of these indices is represented in the total optical score (TOS). Associations between TOS and DAS28 at subject level and OST and swelling at joint level were examined. 484 RA patients were included. Compared to patients with high disease activity (defined by DAS28), TOS was significantly lower in patients with moderate (estimated coefficient B: − 7.09, P < 0.001), low disease activity (B: − 6.99, P < 0.001) and patients in remission (B: − 7.72, P < 0.001) but could not distinguish between the latter three disease states. TOS was significantly lower in females (B: − 3.2, P < 0.001). OST was significantly higher in swollen than non-swollen joints (B: 0.28, P < 0.001). TOS was significantly higher in patients with high disease activity than in those in remission or with low and moderate disease activity. The difference in TOS between males and females should be accounted for in the interpretation of this outcome. The OST at joint level discriminates swollen from non-swollen joints and could be a more promising tool than the overall optical activity reflected in TOS.
- 27 January 2022
- Published by Springer Nature in Rheumatology International
- Vol. 42 (11) , 2019-2026
Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry
The Handscan is a novel objective optical imaging device for disease follow-up and management in rheumatoid arthritis patients. We aim to examine the association between the baseline outcomes of the Handscan, disease activity levels and joint swelling. The Handscan measures differences in laser light absorption between joints of fingers and wrists and adjacent reference tissue, indicating the presence or absence of inflammation. The device gives an optical spectral transmission (OST) index per joint. The average of these indices is represented in the total optical score (TOS). Associations between TOS and DAS28 at subject level and OST and swelling at joint level were examined. 484 RA patients were included. Compared to patients with high disease activity (defined by DAS28), TOS was significantly lower in patients with moderate (estimated coefficient B: − 7.09, P < 0.001), low disease activity (B: − 6.99, P < 0.001) and patients in remission (B: − 7.72, P < 0.001) but could not distinguish between the latter three disease states. TOS was significantly lower in females (B: − 3.2, P < 0.001). OST was significantly higher in swollen than non-swollen joints (B: 0.28, P < 0.001). TOS was significantly higher in patients with high disease activity than in those in remission or with low and moderate disease activity. The difference in TOS between males and females should be accounted for in the interpretation of this outcome. The OST at joint level discriminates swollen from non-swollen joints and could be a more promising tool than the overall optical activity reflected in TOS.
- 15 March 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (1) , e903
Reproducibility and interobserver variability of the RENAL nephrometry score: Senior versus junior radiologists
- 15 March 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (1) , e903
Reproducibility and interobserver variability of the RENAL nephrometry score: Senior versus junior radiologists